...
首页> 外文期刊>OncoTargets and therapy >Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes
【24h】

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes

机译:溶瘤牛痘病毒JX-GFP和TG6002在人黑素瘤体外模型中的免疫原性:研究免疫原性细胞死亡,树突状细胞成熟以及与细胞毒性T淋巴细胞的相互作用

获取原文
           

摘要

Oncolytic virotherapy is an emerging immunotherapeutic modality for cancer treatment. Oncolytic viruses with genetic modifications can further enhance the oncolytic effects on tumor cells and stimulate antitumor immunity. The oncolytic vaccinia viruses JX-594-GFP+/hGM-CSF (JX-GFP) and TG6002 are genetically modified by secreting granulocyte-macrophage colony-stimulating factor (GM-CSF) or transforming 5-fluorocytosine (5-FC) into 5-fluorouracil (5-FU). We compared their properties to kill tumor cells and induce an immunogenic type of cell death in a human melanoma cell model using SK29-MEL melanoma cells. Their influence on human immune cells, specifically regarding the activation of dendritic cells (DCs) and the interaction with the autologous cytotoxic T lymphocyte (CTL) clone, was investigated. Melanoma cells were infected with either JX-GFP or TG6002 alone or in combination with 5-FC and 5-FU. The influence of viral infection on cell viability followed a time- and multiplicity of infection dependent manner. Combination of virus treatment with 5-FU resulted in stronger reduction of cell viability. TG6002 in combination with 5-FC did not significantly strengthen the reduction of cell viability in this setting. Expression of calreticulin and high mobility group 1 protein (HMGB1), markers of immunogenic cell death (ICD), could be detected after viral infection. Accordingly, DC maturation was noted after viral oncolysis. DCs presented stronger expression of activation and maturation markers. The autologous CTL clone IVSB expressed the activation marker CD69, but viral treatment failed to enhance cytotoxicity marker. In summary, vaccinia viruses JX-GFP and TG6002 lyse melanoma cells and induce additional immunostimulatory effects to promote antitumor immune response. Further investigation in vivo is needed to consolidate the data.
机译:溶瘤病毒疗法是一种新兴的用于癌症治疗的免疫疗法。具有基因修饰的溶瘤病毒可以进一步增强对肿瘤细胞的溶瘤作用并刺激抗肿瘤免疫力。溶瘤牛痘病毒JX-594-GFP + / hGM-CSF(JX-GFP)和TG6002通过分泌粒细胞-巨噬细胞集落刺激因子(GM-CSF)或将5-氟胞嘧啶(5-FC)转化为5-来遗传修饰氟尿嘧啶(5-FU)。我们比较了它们在使用SK29-MEL黑色素瘤细胞杀死人黑色素瘤细胞模型中杀死肿瘤细胞并诱导免疫原性细胞死亡的特性。研究了它们对人类免疫细胞的影响,特别是对树突状细胞(DC)的激活以及与自体细胞毒性T淋巴细胞(CTL)克隆的相互作用的影响。黑色素瘤细胞单独感染JX-GFP或TG6002或与5-FC和5-FU联合感染。病毒感染对细胞活力的影响遵循时间依赖性和多重感染依赖性。病毒处理与5-FU的结合可导致细胞活力降低。在这种情况下,TG6002与5-FC的结合并未显着增强细胞活力的降低。病毒感染后可以检测到钙网蛋白和高迁移性第1组蛋白(HMGB1)的表达,这是免疫原性细胞死亡(ICD)的标志。因此,在病毒溶瘤后注意到DC成熟。 DC表现出更强的激活和成熟标记表达。自体CTL克隆IVSB表达了激活标记CD69,但是病毒处理未能增强细胞毒性标记。总之,牛痘病毒JX-GFP和TG6002裂解黑色素瘤细胞并诱导额外的免疫刺激作用,从而促进抗肿瘤免疫反应。需要进一步的体内研究以巩固数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号